Lipid Abnormalities During Saquinavir Soft-Gel–Based Highly Active Antiretroviral Therapy
- 15 August 1999
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 21 (5) , 423
- https://doi.org/10.1097/00042560-199908150-00011
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efavirenz: shifting the HAART paradigm in adult HIV-1 infectionExpert Opinion on Investigational Drugs, 1999
- Coronary artery disease occurring with protease inhibitor therapyInternational Journal of STD & AIDS, 1998
- Marked hypertriglyceridaemia associated with ritonavir therapyAIDS, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirAIDS, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998